Show simple item record

dc.contributor.authorERCAN, ÇİLEM
dc.contributor.authorYAMAÇ, AYLİN HATİCE
dc.date.accessioned2019-10-05T13:44:03Z
dc.date.available2019-10-05T13:44:03Z
dc.date.issued2015-04-01
dc.identifier
dc.identifier.urihttps://hdl.handle.net/20.500.12645/2847
dc.description.abstractIncreased serum levels of the activated aspartic lysosomal endopeptidase cathepsin D (CatD) have been found in patients with acute myocardial infarction (AMI). However, to date there have been no analyses of clinical follow-up data measuring the enzyme course and its role in the development of post-MI heart failure. This study aimed to evaluate the role of serum CatD activity in the development of heart failure in patients with ST-segment elevation acute myocardial infarction (STEMI).
dc.language.isoen
dc.subjectYAMAÇ A. H. , ERCAN Ç., -Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI-, HERZ, no.6, ss.912-920, 2015
dc.titleRole of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI
dc.typeArticle
local.avesis.response2717
local.article.journalnameMeme Hastalıkları Dergisi,
local.org.facultyTıp Fakültesi
dc.contributor.institutionauthorERCAN, ÇİLEM


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record